Jinlong Ji
Suzhou, 215123, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Single-fraction radiotherapy with a bioactive depot of CD39 blockade eradicates malignant tumors.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 24, 2025
Smad7 drives cisplatin resistance in ovarian cancer via a PRMT5-dependent mechanism.
Journal: Tissue & cell
Published: May 17, 2025
Liposomal all-trans retinoic acid boosts anti-tumor immunity of radiotherapy via mitigating cancer stemness and remedying tumor microenvironment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 06, 2025
Co-activating STING-TLR9 pathways promotes radiotherapy-induced cancer vaccination.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 08, 2024
Tumor-Adhesive Chitosan-Derived Multi-Immune Agonist Unleashes Strong and Durable Anti-Cancer Immunity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 01, 2024
REG3A promotes proliferation and DDP resistance of ovarian cancer cells by activating the PI3K/Akt signaling pathway.
Journal: Environmental toxicology
Published: February 02, 2023
Association of hyperglycaemia with the placenta of GDM-induced macrosomia with normal pre-pregnancy BMI and the proliferation of trophoblast cells.
Journal: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
Published: March 09, 2022
Fibronectin 1 inhibits the apoptosis of human trophoblasts by activating the PI3K/Akt signaling pathway.
Journal: International journal of molecular medicine
Published: December 08, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026